FDA clears CAD between Fischer Imaging and R2 Technology

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has given the go-ahead to Fischer Imaging Corp. and R2 Technology Inc. to integrate their respective technologies.

 The ruling allows Fischer Imaging to integrate its SenoScan digital mammography system with R2's computer-aided detection (CAD) technology. In addition, R2 Technology's ImageChecker DM analog system -- which received FDA clearance in September -- also will support CAD analysis of digital images acquired on the SenoScan system.

 The ImageChecker DM System will be distributed directly by Fischer and R2.